Cargando…

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass

Serum autoantibodies against the p53 protein (p53 AAb) were analysed with a newly developed enzyme-linked immunosorbent assay (ELISA) based on highly purified and renatured p53. In a hospital-based cohort study, preoperative sera from 113 patients with ovarian cancer, 15 patients with borderline tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vogl, F D, Frey, M, Kreienberg, R, Runnebaum, I B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408792/ https://www.ncbi.nlm.nih.gov/pubmed/11044359 http://dx.doi.org/10.1054/bjoc.2000.1446

Ejemplares similares

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
por: Regele, S, et al.
Publicado: (1999)

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
por: Wang-Gohrke, S, et al.
Publicado: (1999)

p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.
por: Runnebaum, I. B., et al.
Publicado: (1996)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
por: Anttila, M A, et al.
Publicado: (1999)

Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000)

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
por: Vermeulen, P B, et al.
Publicado: (1999)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

C-erbB-2 overexpression in primary breast cancer: relationship to clinical and histopathological parameters of patients with breast cancer
por: Regele, S, et al.
Publicado: (2001)

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction
por: Kupryjánczyk, J, et al.
Publicado: (2000)

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
por: Nordsmark, M, et al.
Publicado: (2001)

High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer
por: Iwadate, Reiko, et al.
Publicado: (2014)

Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis
por: Ilić, Duško, et al.
Publicado: (1998)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder
por: Niehans, G A, et al.
Publicado: (1999)

Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999)

The High Expression of p53 Is Predictive of Poor Survival Rather TP53 Mutation in Esophageal Squamous Cell Carcinoma
por: Jin, Yan, et al.
Publicado: (2023)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
por: Köbel, Martin, et al.
Publicado: (2023)

Selective in vitro cytotoxicity effect of Drimia calcarata bulb extracts against p53 mutant HT-29 and p53 wild-type Caco-2 colorectal cancer cells through STAT5B regulation
por: Laka, K., et al.
Publicado: (2021)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995)

Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma
por: Akiyama, Azusa, et al.
Publicado: (2019)

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
por: Lenner, P, et al.
Publicado: (1999)

Increased p53 protein content of colorectal tumours correlates with poor survival.
por: Remvikos, Y., et al.
Publicado: (1992)

Expression of transcription factor AP-2α predicts survival in epithelial ovarian cancer
por: Anttila, M A, et al.
Publicado: (2000)

In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
por: Emanuels, A G, et al.
Publicado: (1999)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Proteolytic cleavage of p53 mutants in response to mismatched DNA
por: Mee, T, et al.
Publicado: (1999)

Linker DNA and histone contributions in nucleosome binding by p53
por: Nishimura, Masahiro, et al.
Publicado: (2020)

The expression of p73 is increased in lung cancer, independent of p53 gene alteration
por: Tokuchi, Y, et al.
Publicado: (1999)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999)

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
por: Paradiso, A, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_dj2br7h8j0go0gr0kmv9ekfcag